Excellent points. I am worried about all the corruption in Russia (1), the possibility that trial results are weak, and no better than placebo (2), the fact that natural substances cannot be patented (2), and the smoke and mirrors regarding Ropren approval and production (3).
We desperately need more transparency. This should come with the raising, as investors will demand more timely disclosure.
Great first post.
